Adding Value to Life Sciences Investments

  • Home
  • About
  • News & Events
  • Portfolio
  • Contact
  • Events
  • Press Releases

Recent Press Releases

  • Archived

May 16, 2011
NeuroHealing Announces Strategic Master Services and Investment Agreement with Cato BioVentures PDF

January 10, 2011
Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP PDF

2010

October, 2010
Cato Research's Daniel Pharand is published in this month's issue of Biotechnology Focus - Those That Adapt to Change Will Survive

September 27, 2010
Advanced Targeting Systems Announces $3 Million Award from National Cancer Institute

May 20, 2010
Merge Healthcare and Cato Research Establish New Five-Year Technology Transfer Agreement PDF

February 11, 2010
Neuren forms strategic partnership with Cato BioVentures, Appoints US Chief Medical Officer PDF

Portfolio

  • Cato Bioventures - Abeome
  • Cato Bioventures - Alseres
  • Cato Bioventures - Apr
  • Cato Bioventures - Biomarck
  • Cato Bioventures - Biothera
  • Cato Bioventures - Cancer Advances
  • Cato Bioventures - Catena
  • Cato Bioventures - Compellis
  • Cato Bioventures - Cordex
  • Cato Bioventures - Cumberland Pharmaceuticals
  • Cato Bioventures - Echo
  • Cato Bioventures - Emmaus
  • Cato Bioventures - Entremed
  • Cato Bioventures - Etrials
  • Cato Bioventures - FirstString Research
  • Cato Bioventures - HTI
  • Cato Bioventures - Immunovaccine
  • Cato Bioventures - InnerOptic Technology
  • Cato Bioventures - Mithridion
  • Cato Bioventures - Neuren
  • Cato Bioventures - Sanogene
  • Cato Bioventures - Vistagen
  • Cato Bioventures - Wavi

Contact Us

Phone: 919.361.2286 Email: cbvinfo@cato.com Fax: 919.361.2290 Voice: 919.361.2099

Cato Research | Home | About | News & Events | Portfolio | Contact
© Cato BioVentures. All rights reserved.